Trials / Sponsors / Jin Hyoung Kang
Jin Hyoung Kang
Academic / Other · 2 registered clinical trials.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Unknown | Lazertinib/Pemetrexed/Carboplatin After Osimertinib Failure in NSCLC With Brain Metastases Non-small Cell Lung Cancer | Phase 2 | 2022-08-01 |
| Unknown | Lazertinib in Patients With NSCLC With Asymptomatic or Mild Symptomatic Brain Metastases After Failure of EGFR Lung Neoplasms | Phase 2 | 2021-06-23 |